Published in Cancer Invest on January 01, 1986
Phenotype and genotype of pancreatic cancer cell lines. Pancreas (2010) 3.06
A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. Virchows Arch (2003) 2.53
Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer. Clin Cancer Res (2008) 1.82
Pancreatic carcinomas deposit laminin-5, preferably adhere to laminin-5, and migrate on the newly deposited basement membrane. Am J Pathol (1997) 1.16
Distinct phospho-forms of cortactin differentially regulate actin polymerization and focal adhesions. Am J Physiol Cell Physiol (2008) 1.15
VE-cadherin expression and clustering maintain low levels of survivin in endothelial cells. Am J Pathol (2004) 1.03
Differential and antagonistic effects of 9-cis-retinoic acid and vitamin D analogues on pancreatic cancer cells in vitro. Br J Cancer (2000) 1.01
Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells. Oncotarget (2015) 0.99
Microarray analysis of cytoplasmic versus whole cell RNA reveals a considerable number of missed and false positive mRNAs. RNA (2009) 0.98
Phosphorylation of CK1delta: identification of Ser370 as the major phosphorylation site targeted by PKA in vitro and in vivo. Biochem J (2007) 0.98
Membrane-bound and exosomal metastasis-associated C4.4A promotes migration by associating with the α(6)β(4) integrin and MT1-MMP. Neoplasia (2012) 0.97
Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX. PLoS One (2012) 0.97
Growth of human pancreatic cancer is inhibited by down-regulation of gastrin gene expression. Pancreas (2009) 0.95
Phosphorylation on Ser-279 and Ser-282 of connexin43 regulates endocytosis and gap junction assembly in pancreatic cancer cells. Mol Biol Cell (2013) 0.95
PET imaging of inflammation and adenocarcinoma xenografts using vascular adhesion protein 1 targeting peptide 68Ga-DOTAVAP-P1: comparison with 18F-FDG. Eur J Nucl Med Mol Imaging (2010) 0.92
Membrane proteomic analysis of pancreatic cancer cells. J Biomed Sci (2010) 0.92
Nanoelectroablation of human pancreatic carcinoma in a murine xenograft model without recurrence. Int J Cancer (2012) 0.92
Expression of organic anion-transporting polypeptides 1B3, 1B1, and 1A2 in human pancreatic cancer reveals a new class of potential therapeutic targets. Onco Targets Ther (2011) 0.91
MUC1 selectively targets human pancreatic cancer in orthotopic nude mouse models. PLoS One (2015) 0.89
The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer. Mol Cancer (2008) 0.89
Role of α(5)β(1) Integrin Up-regulation in Radiation-Induced Invasion by Human Pancreatic Cancer Cells. Transl Oncol (2011) 0.88
Insulin-like growth factor 1 receptor (IGF-1R) as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer. PLoS One (2014) 0.88
The anti-tumor effect of HDAC inhibition in a human pancreas cancer model is significantly improved by the simultaneous inhibition of cyclooxygenase 2. PLoS One (2013) 0.88
Analysis of the cytochrome c-dependent apoptosis apparatus in cells from human pancreatic carcinoma. Br J Cancer (2002) 0.87
FGF-1 and FGF-2 modulate the E-cadherin/catenin system in pancreatic adenocarcinoma cell lines. Br J Cancer (2001) 0.87
Holoclone forming cells from pancreatic cancer cells enrich tumor initiating cells and represent a novel model for study of cancer stem cells. PLoS One (2011) 0.87
Characterization of novel diaryl oxazole-based compounds as potential agents to treat pancreatic cancer. J Pharmacol Exp Ther (2009) 0.84
A combinatorial approach for the design of complementarity-determining region-derived peptidomimetics with in vitro anti-tumoral activity. J Biol Chem (2009) 0.84
Frankincense essential oil prepared from hydrodistillation of Boswellia sacra gum resins induces human pancreatic cancer cell death in cultures and in a xenograft murine model. BMC Complement Altern Med (2012) 0.83
Evaluation of a gene-directed enzyme-product therapy (GDEPT) in human pancreatic tumor cells and their use as in vivo models for pancreatic cancer. PLoS One (2012) 0.82
Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice. J Thromb Haemost (2015) 0.81
Opioid growth factor and the treatment of human pancreatic cancer: a review. World J Gastroenterol (2014) 0.81
CD109 Overexpression in Pancreatic Cancer Identified by Cell-Surface Glycoprotein Capture. J Proteomics Bioinform (2015) 0.80
Prolyl-4-hydroxylase 3 (PHD3) expression is downregulated during epithelial-to-mesenchymal transition. PLoS One (2013) 0.80
Relevance of amyloid precursor-like protein 2 C-terminal fragments in pancreatic cancer cells. Int J Oncol (2012) 0.80
Universal antibody conjugation to nanoparticles using the Fcγ receptor I (FcγRI): quantitative profiling of membrane biomarkers. Bioconjug Chem (2014) 0.79
Endostatin expression in a pancreatic cell line is modulated by a TNFalpha-dependent elastase. Br J Cancer (2005) 0.78
Isolation of Pancreatic Cancer Cells from a Patient-Derived Xenograft Model Allows for Practical Expansion and Preserved Heterogeneity in Culture. Am J Pathol (2016) 0.78
Coordinate regulation of the gel-forming mucin genes at chromosome 11p15.5. J Biol Chem (2013) 0.78
Translational assessment of mitochondrial dysfunction of pancreatic cancer from in vitro gene microarray and animal efficacy studies, to early clinical studies, via the novel tumor-specific anti-mitochondrial agent, CPI-613. Ann Transl Med (2014) 0.78
Injectable polypeptide micelles that form radiation crosslinked hydrogels in situ for intratumoral radiotherapy. J Control Release (2016) 0.77
Insights Into SMAD4 Loss in Pancreatic Cancer From Inducible Restoration of TGF-β Signaling. Mol Endocrinol (2015) 0.77
Generation of an in vitro 3D PDAC stroma rich spheroid model. Biomaterials (2016) 0.77
Targeting the insulin growth factor-1 receptor with fluorescent antibodies enables high resolution imaging of human pancreatic cancer in orthotopic mouse models. Oncotarget (2016) 0.76
Impact of Diverse Immune Evasion Mechanisms of Cancer Cells on T Cells Engaged by EpCAM/CD3-Bispecific Antibody Construct AMG 110. PLoS One (2015) 0.76
Potentiation of ionising radiation by targeting tumour necrosis factor alpha using a bispecific antibody in human pancreatic cancer. Br J Cancer (2003) 0.75
The small heat shock protein αA-crystallin negatively regulates pancreatic tumorigenesis. Oncotarget (2016) 0.75
Lack of evidence for MHC-unrestricted (atypical) recognition of mucin by mucinous pancreatic tumour-reactive T-cells. Br J Cancer (2000) 0.75
Basal metabolic state governs AIF-dependent growth support in pancreatic cancer cells. BMC Cancer (2016) 0.75
L-Methionine inhibits growth of human pancreatic cancer cells. Anticancer Drugs (2014) 0.75
Acquired resistance of pancreatic cancer cells to cisplatin is multifactorial with cell context-dependent involvement of resistance genes. Cancer Gene Ther (2016) 0.75
Immunological and Functional Characterization of RhoGDI3 and Its Molecular Targets RhoG and RhoB in Human Pancreatic Cancerous and Normal Cells. PLoS One (2016) 0.75
Effects of a histone deacetylase inhibitor, sodium butyrate, on 53-kDa protein expression and sensitivity to anticancer drugs of pancreatic cancer cells. Curr Ther Res Clin Exp (2010) 0.75
Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers. J Nucl Med (2016) 0.75
LNCaP model of human prostatic carcinoma. Cancer Res (1983) 7.23
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med (1980) 6.12
Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med (1981) 5.44
Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell (1998) 4.72
Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg (1978) 3.37
Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med (1993) 3.37
Genetics of natural resistance to herpesvirus infections in mice. Nature (1975) 3.18
Purification of a human prostate specific antigen. Invest Urol (1979) 3.11
The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses. Arch Virol (1992) 3.09
The LNCaP cell line--a new model for studies on human prostatic carcinoma. Prog Clin Biol Res (1980) 2.97
Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides. J Med Chem (1979) 2.80
Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet (1986) 2.78
Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer (1983) 2.59
Carcinoembryonic antigen in patients with different cancers. JAMA (1972) 2.56
Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc Natl Acad Sci U S A (1986) 2.27
Quantitative immunohistochemical determination of 8-hydroxy-2'-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest (1997) 2.25
Survival after postoperative combination treatment of rectal cancer. N Engl J Med (1986) 2.24
The journal "impact factor": a misnamed, misleading, misused measure. Cancer Genet Cytogenet (1998) 2.23
The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial. Ann Intern Med (1994) 2.08
Metastases from carcinoma of mammary gland: an autopsy study. J Surg Oncol (1979) 2.06
Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer (1999) 1.99
2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent. Antimicrob Agents Chemother (1980) 1.96
Culture of human leukemia cells. Cancer (1966) 1.94
Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody. Infect Immun (1979) 1.94
Carcinoembryonic antigen (CEA) as a prognostic and monitoring test in clinically complete resection of colorectal carcinoma. Ann Surg (1976) 1.92
Disappearance of a structural chromatin protein A24 in mitosis: implications for molecular basis of chromatin condensation. Proc Natl Acad Sci U S A (1979) 1.91
Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83
Metastasis to organs in carcinoma of the uterine cervix. Influence of treatment on incidence and distribution. Cancer (1968) 1.78
Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms. Cancer (1981) 1.73
The changing histopathology of lung cancer: a review of 1682 cases. Cancer (1977) 1.72
Intrachromosomal genomic instability in human sporadic colorectal cancer measured by genome-wide allelotyping and inter-(simple sequence repeat) PCR. Cancer Res (2001) 1.69
Structure of rice ferricytochrome c at 2.0 A resolution. J Mol Biol (1983) 1.67
Gene therapy progress and prospects: the eye. Gene Ther (2006) 1.66
Accuracy of CT-guided needle biopsy of musculoskeletal neoplasms. AJR Am J Roentgenol (1998) 1.59
Carcinoembryonic antigen (CEA) in patients with carcinoma of the digestive tract. Ann Surg (1972) 1.59
Positional cloning of a gene involved in hereditary multiple exostoses. Hum Mol Genet (1996) 1.58
The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group. J Clin Oncol (1989) 1.53
Linkage-disequilibrium mapping without genotyping. Nat Genet (1998) 1.52
Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). II. Biomarker studies. Cancer (1985) 1.51
Cell-mediated immune responses in recurrent herpesvirus infections. I. Lymphocyte proliferation assay. J Immunol (1977) 1.51
An autopsy study of the metastatic patterns of human leukemias. Oncology (1978) 1.50
Diagnosis of chronic liver disease from liver scintiscans by fuzzy reasoning. J Nucl Med (1995) 1.50
Soft tissue sarcomas. Ann Surg (1975) 1.49
Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet (1986) 1.49
The Torg--Pavlov ratio in cervical spondylotic myelopathy: a comparative study between patients with cervical spondylotic myelopathy and a nonspondylotic, nonmyelopathic population. Spine (Phila Pa 1976) (2001) 1.49
Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). I. Clinical description of resource. Cancer (1985) 1.48
Toward an ecosocial view of health. Int J Health Serv (1999) 1.47
Accuracy of magnetic resonance imaging of inguinofemoral lymph nodes in vulval cancer. Int J Gynecol Cancer (2006) 1.47
Isopeptidase: a novel eukaryotic enzyme that cleaves isopeptide bonds. Proc Natl Acad Sci U S A (1982) 1.47
Isolation of a virus from the lungs of Montana sheep affected with progressive pneumonia. Virology (1968) 1.46
Divergently transcribed overlapping genes expressed in liver and kidney and located in the 11p15.5 imprinted domain. Genomics (1998) 1.45
An outbreak of rabies in dogs in the state of Terengganu 1995-1996. Med J Malaysia (1998) 1.45
Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor. J Clin Oncol (1984) 1.44
Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Mult Scler (2008) 1.44
A reverse flow-metabolism mismatch pattern on PET is related to multivessel disease in patients with acute myocardial infarction. J Nucl Med (1999) 1.43
No relationship between carbohydrate intake and effect of acarbose on HbA1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrate. Diabetes Care (1998) 1.42
High incidence of silent venous thromboembolism before treatment in ovarian cancer. Br J Cancer (2007) 1.42
Convention on nomenclature for DNA cytometry. Committee on Nomenclature, Society for Analytical Cytology. Cancer Genet Cytogenet (1984) 1.42
Squamous metaplasia and squamous-cell carcinoma of the rectosigmoid. Dis Colon Rectum (1967) 1.41
Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites. In Vitro (1982) 1.39
Descriptive terms used by Malay patients for exertional angina pectoris. Med J Malaysia (1994) 1.39
Trisomy 14: a new entity within acute nonlymphocytic leukemia. Cancer Genet Cytogenet (1989) 1.39
Involvement of 6p in benign lipomas. A new cytogenetic entity? Cancer Genet Cytogenet (1989) 1.39
Histology and prevalence of ovarian tumours in postmenopausal women: is follow-up required in all cases? J Obstet Gynaecol (2012) 1.38
Metastatic tumor to the tongue. Report of twelve cases. Oral Surg Oral Med Oral Pathol (1973) 1.38
Insulin availability among International Diabetes Federation member associations. Report of the Task Force on Insulin Distribution. Diabetes Care (1994) 1.37
Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets. J Immunol (1983) 1.37
Cytomegalovirus: Clinical virological correlations in renal transplant recipients. Ann Surg (1974) 1.34
CEA as a monitor of gastrointestinal malignancy. Cancer (1975) 1.33
Isolation and characterization of free radical scavenging activities peptides derived from casein. J Nutr Biochem (2000) 1.33
1,000 consecutive ultrasounds for blunt abdominal trauma. J Trauma (1996) 1.31
Facilitation or attenuation of mixed leukocyte culture responsiveness by adherent cells. Nature (1976) 1.31
An autopsy study of metastatic sites of breast cancer. Cancer Res (1973) 1.30
Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys (1998) 1.29
Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-2'-deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment. FEBS Lett (1997) 1.29
Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes. Diabetologia (2005) 1.29
Bestrophin gene mutations in patients with Best vitelliform macular dystrophy. Genomics (1999) 1.29
Hybridization of nuclear matrix attached deoxyribonucleic acid fragments. Biochemistry (1981) 1.26
Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection. Hepatology (1998) 1.26
Causes of death in cancer patients. J Med (1975) 1.26
Translocation X;18 in synovial sarcoma. Cancer Genet Cytogenet (1986) 1.26
An autopsy study of some routes of dissemination of cancer of the breast. Br J Cancer (1973) 1.25
Carcinoembryonic antigen in patients with carcinoma of the lung. J Thorac Cardiovasc Surg (1973) 1.24
High-level transient expression of influenza virus proteins from a series of SV40 late and early replacement vectors. Gene (1988) 1.24
Role of virus infections in immunosuppressed renal transplant patients. Transplant Proc (1973) 1.23
Differential hydration of dA.dT base pairing and dA and dT bulges in deoxyoligonucleotides. Biochemistry (1991) 1.23
Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity. J Clin Invest (1986) 1.23
Clonal chromosomal abnormalities in desmoid tumors. Implications for histopathogenesis. Cancer (1992) 1.23
Identification of a nucleocapsid protein as a specific serological marker of human herpesvirus 6 infection. J Clin Microbiol (1990) 1.23
Growth properties of human herpesvirus-6 strain Z29. J Virol Methods (1989) 1.23
Fracture of the outlet strut of a Björk-Shiley mitral prosthesis: emergency operation with survival. J Thorac Cardiovasc Surg (1984) 1.23
Relation between aortic atherosclerosis and the use of cigarettes and alcohol. An autopsy study. N Engl J Med (1968) 1.23
Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275). Cancer (1985) 1.23
Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma. Cancer Res (1986) 1.22